Evergreen Capital Management LLC raised its position in Lam Research Co. (NASDAQ:LRCX - Free Report) by 842.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,133 shares of the semiconductor company's stock after purchasing an additional 7,270 shares during the period. Evergreen Capital Management LLC's holdings in Lam Research were worth $589,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also modified their holdings of the company. Parisi Gray Wealth Management grew its position in shares of Lam Research by 652.9% in the 4th quarter. Parisi Gray Wealth Management now owns 8,350 shares of the semiconductor company's stock valued at $603,000 after buying an additional 7,241 shares during the last quarter. Burns J W & Co. Inc. NY acquired a new stake in shares of Lam Research during the fourth quarter worth about $815,000. Centerpoint Advisors LLC lifted its holdings in shares of Lam Research by 900.0% in the 4th quarter. Centerpoint Advisors LLC now owns 1,000 shares of the semiconductor company's stock valued at $72,000 after purchasing an additional 900 shares during the last quarter. Transform Wealth LLC acquired a new stake in shares of Lam Research in the 4th quarter valued at about $17,269,000. Finally, E. Ohman J or Asset Management AB purchased a new position in Lam Research during the 4th quarter worth approximately $4,258,000. 84.61% of the stock is owned by hedge funds and other institutional investors.
Lam Research Trading Up 6.1 %
NASDAQ LRCX traded up $4.10 during mid-day trading on Thursday, reaching $70.83. 9,253,675 shares of the stock were exchanged, compared to its average volume of 12,148,253. The business's fifty day simple moving average is $73.69 and its 200 day simple moving average is $75.62. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.73 and a current ratio of 2.54. The stock has a market capitalization of $90.92 billion, a PE ratio of 21.46, a PEG ratio of 1.47 and a beta of 1.52. Lam Research Co. has a 1-year low of $56.32 and a 1-year high of $113.00.
Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The semiconductor company reported $1.04 EPS for the quarter, beating analysts' consensus estimates of $1.00 by $0.04. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. The business had revenue of $4.72 billion during the quarter, compared to the consensus estimate of $4.64 billion. On average, research analysts anticipate that Lam Research Co. will post 3.71 earnings per share for the current fiscal year.
Lam Research Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, April 9th. Investors of record on Wednesday, March 5th were given a $0.23 dividend. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $0.92 annualized dividend and a dividend yield of 1.30%. Lam Research's dividend payout ratio is presently 27.96%.
Insider Buying and Selling
In other news, SVP Seshasayee Varadarajan sold 110,080 shares of the company's stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $90.00, for a total value of $9,907,200.00. Following the completion of the sale, the senior vice president now owns 179,084 shares of the company's stock, valued at $16,117,560. This represents a 38.07 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.29% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on the stock. Stifel Nicolaus lowered their price objective on shares of Lam Research from $100.00 to $92.00 and set a "buy" rating on the stock in a research report on Tuesday, April 15th. UBS Group cut their price target on Lam Research from $95.00 to $90.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Susquehanna upgraded shares of Lam Research from a "neutral" rating to a "positive" rating and lifted their price objective for the company from $75.00 to $125.00 in a research report on Thursday, February 20th. Barclays cut their price objective on shares of Lam Research from $75.00 to $70.00 and set an "equal weight" rating for the company in a research report on Tuesday. Finally, Mizuho lifted their target price on shares of Lam Research from $87.00 to $100.00 and gave the company an "outperform" rating in a report on Thursday, February 20th. Six investment analysts have rated the stock with a hold rating and twenty have assigned a buy rating to the company's stock. Based on data from MarketBeat, Lam Research presently has a consensus rating of "Moderate Buy" and a consensus price target of $93.49.
Read Our Latest Stock Analysis on Lam Research
Lam Research Company Profile
(
Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Further Reading

Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.